Peiyu Xu
- Molecular Biology top 10%
- Cellular and Molecular Neuroscience top 5%
- Endocrinology, Diabetes and Metabolism top 10%
- Radiology, Nuclear Medicine and Imaging
- Spectroscopy top 10%
- Topics
- Receptor Mechanisms and Signaling (17 papers)Carcinogens and Genotoxicity Assessment (6 papers)RNA and protein synthesis mechanisms (5 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Peiyu Xu
42 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Molecular Biology 975
- Cellular and Molecular Neuroscience 368
- Endocrinology, Diabetes and Metabolism 131
- Radiology, Nuclear Medicine and Imaging 110
- Spectroscopy 91
Countries citing papers authored by Peiyu Xu
This map shows the geographic impact of Peiyu Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peiyu Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peiyu Xu more than expected).
Fields of papers citing papers by Peiyu Xu
This network shows the impact of papers produced by Peiyu Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peiyu Xu. The network helps show where Peiyu Xu may publish in the future.
Co-authorship network of co-authors of Peiyu Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Peiyu Xu. A scholar is included among the top collaborators of Peiyu Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peiyu Xu. Peiyu Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 17 | |
| 3 | 8 | |
| 4 | 3 | |
| 5 | 34 | |
| 6 | 12 | |
| 7 | 30 | |
| 8 | Fanzor is a eukaryotic programmable RNA-guided endonucleasebreakdown → | 120 |
| 9 | 2 | |
| 10 | 71 | |
| 11 | 41 | |
| 12 | 36 | |
| 13 | 39 | |
| 14 | 49 | |
| 15 | Structural insights into the lipid and ligand regulation of serotonin receptorsbreakdown → | 185 |
| 16 | 57 | |
| 17 | 69 | |
| 18 | 60 | |
| 19 | [Experimental studies on male reproductive toxicity of bisphenol A in vitro and vivo]. | 2 |
| 20 | [The effects of three plastic additives on the proliferation of MCF-7 cell]. | 2 |
About Peiyu Xu
Peiyu Xu is a scholar working on Molecular Biology, Cancer Research and Animal Science and Zoology, having authored 46 papers that have together received 1.5k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (17 papers), Carcinogens and Genotoxicity Assessment (6 papers) and RNA and protein synthesis mechanisms (5 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (368 citations), Molecular Biology (975 citations) and Biochemistry (74 citations). Peiyu Xu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include H. Eric Xu, Yi Jiang, Yan Zhang, Sijie Huang, Xinheng He, Dandan Shen, Hong Gao, Hualiang Jiang, Yina Huang and Chunyou Mao. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.